Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 109

1.

Use of remote control in the intraoperative telemetry of cochlear implant: multicentric study.

Tanamati LF, Goffi-Gomez MVS, Muniz LF, Samuel PA, Wiemes GRM, Lima DP, Curi SB, Onuki LC, Queiroz CF, Capistrano AKB, Moret ALM, Kimura MYT, Oyanguren V, Mauch H.

Braz J Otorhinolaryngol. 2019 Jul - Aug;85(4):502-509. doi: 10.1016/j.bjorl.2018.04.003. Epub 2018 May 18.

2.

Long Persistence of a Streptococcus pneumoniae 23F Clone in a Cystic Fibrosis Patient.

Rieger M, Mauch H, Hakenbeck R.

mSphere. 2017 Jun 7;2(3). pii: e00201-17. doi: 10.1128/mSphere.00201-17. eCollection 2017 May-Jun.

3.

Bedaquiline as a potential agent in the treatment of Mycobacterium abscessus infections.

Vesenbeckh S, Schönfeld N, Roth A, Bettermann G, Krieger D, Bauer TT, Rüssmann H, Mauch H.

Eur Respir J. 2017 May 21;49(5). pii: 1700083. doi: 10.1183/13993003.00083-2017. Print 2017 May. No abstract available.

4.

Bedaquiline as a potential agent in the treatment of M. intracellulare and M. avium infections.

Vesenbeckh S, Schönfeld N, Krieger D, Bettermann G, Bauer TT, Rüssmann H, Mauch H.

Eur Respir J. 2017 Mar 22;49(3). pii: 1601969. doi: 10.1183/13993003.01969-2016. Print 2017 Mar. No abstract available.

5.

In reply.

Otto-Knapp R, Vesenbeckh S, Schönfeld N, Bettermann G, Roth A, Bauer T, Rüssmann H, Mauch H.

Int J Tuberc Lung Dis. 2017 Jan 1;21(1):123. doi: 10.5588/ijtld.16.0689-2. No abstract available.

PMID:
28157479
6.

Is delamanid a potential agent in the treatment of diseases caused by Mycobacterium avium-intracellulare?

Krieger D, Schönfeld N, Vesenbeckh S, Bettermann G, Bauer TT, Rüssmann H, Mauch H.

Eur Respir J. 2016 Dec;48(6):1803-1804. doi: 10.1183/13993003.01420-2016. Epub 2016 Nov 11. No abstract available.

7.

Isoniazid minimal inhibitory concentrations of tuberculosis strains with katG mutation.

Otto-Knapp R, Vesenbeckh S, Schönfeld N, Bettermann G, Roth A, Bauer T, Rüssmann H, Mauch H.

Int J Tuberc Lung Dis. 2016 Sep;20(9):1275-6. doi: 10.5588/ijtld.16.0148. No abstract available.

PMID:
27510258
8.

Neuroleptic drugs in the treatment of tuberculosis: Minimal inhibitory concentrations of different phenothiazines against Mycobacterium tuberculosis.

Vesenbeckh S, Krieger D, Bettermann G, Schönfeld N, Bauer TT, Rüssmann H, Mauch H.

Tuberculosis (Edinb). 2016 May;98:27-9. doi: 10.1016/j.tube.2016.02.003. Epub 2016 Feb 26.

PMID:
27156615
9.

Recommendations of the German Central Committee against Tuberculosis (DZK) and the German Respiratory Society (DGP) for the Diagnosis and Treatment of Non-tuberculous Mycobacterioses.

Schoenfeld N, Haas W, Richter E, Bauer T, Boes L, Castell S, Hauer B, Magdorf K, Matthiessen W, Mauch H, Reuss A, Schenkel K, Ruesch-Gerdes S, Zabel P, Dalhoff K, Schaberg T, Loddenkemper R.

Pneumologie. 2016 Apr;70(4):250-76. doi: 10.1055/s-0041-111494. Epub 2016 Apr 11. Review.

10.

Mefloquine as a potential drug against multidrug-resistant tuberculosis.

Krieger D, Vesenbeckh S, Schönfeld N, Bettermann G, Bauer TT, Rüssmann H, Mauch H.

Eur Respir J. 2015 Nov;46(5):1503-5. doi: 10.1183/13993003.00321-2015. Epub 2015 Jul 23. No abstract available.

11.

The Intra-Cochlear Impedance-Matrix (IIM) test for the Nucleus® cochlear implant.

Hey M, Böhnke B, Dillier N, Hoppe U, Eskilsson G, Löwgren K, Cullington H, Mauch H, Müller-Deile J.

Biomed Tech (Berl). 2015 Apr;60(2):123-33. doi: 10.1515/bmt-2014-0058.

PMID:
25720032
12.

Low minimal inhibitory concentrations of linezolid against multidrug-resistant tuberculosis strains.

Weiss T, Schönfeld N, Otto-Knapp R, Bös L, Bettermann G, Mauch H, Bauer TT, Rüssmann H.

Eur Respir J. 2015 Jan;45(1):285-7. doi: 10.1183/09031936.00084614. No abstract available.

13.

[Pathogenicity of Mycobacterium kansasii].

Vesenbeckh S, Wagner S, Mauch H, Roth A, Streubel A, Rüssmann H, Bauer TT, Matthiessen W, Schönfeld N.

Pneumologie. 2014 Aug;68(8):526-31. doi: 10.1055/s-0034-1377288. Epub 2014 Jul 21. German.

14.

[Resistance to second-line drugs in migrants with multidrug-resistant tuberculosis in the Berlin region].

Otto-Knapp R, Bös L, Schönfeld N, Wagner S, Starzacher AK, Weiss T, Vesenbeckh S, Glaser-Paschke G, Mauch H, Rüssmann H, Bauer TT.

Pneumologie. 2014 Jul;68(7):496-500. doi: 10.1055/s-0034-1377226. Epub 2014 Jul 9. German.

15.

[Recommendations for diagnosis and treatment of nontuberculous mycobacterioses of the German Central Committee against tuberculosis and the German Respiratory Society].

Schönfeld N, Haas W, Richter E, Bauer TT, Bös L, Castell S, Hauer B, Magdorf K, Matthiessen W, Mauch H, Reuss A, Rüsch-Gerdes S, Zabel P, Dalhoff K, Schaberg T, Loddenkemper R.

Pneumologie. 2013 Nov;67(11):605-33. doi: 10.1055/s-0033-1344790. Epub 2013 Nov 6. German.

16.

Minimal inhibitory concentrations of first-line drugs of multidrug-resistant tuberculosis isolates.

Schönfeld N, Bergmann T, Vesenbeckh S, Mauch H, Bettermann G, Bauer TT, Rüssmann H.

Lung India. 2012 Oct;29(4):309-12. doi: 10.4103/0970-2113.102794.

17.

In vitro susceptibility of Mycobacterium bovis against moxifloxacin.

Weiss T, Schönfeld N, Bettermann G, Blum TG, Kollmeier J, Mauch H, Bauer TT, Rüssmann H.

Int J Tuberc Lung Dis. 2012 Nov;16(11):1562. doi: 10.5588/ijtld.12.0042. No abstract available.

PMID:
23044455
18.

The use of interferon gamma release assays in the diagnosis of active tuberculosis.

Vesenbeckh SM, Schönfeld N, Mauch H, Bergmann T, Wagner S, Bauer TT, Rüssmann H.

Tuberc Res Treat. 2012;2012:768723. doi: 10.1155/2012/768723. Epub 2012 Jan 22.

19.

[Interferon-gamma release assays for hospital-based tuberculosis diagnostics in children and adolescents--a retrospective analysis].

Knappik M, Schönfeld N, Günther A, Bergmann T, Magdorf K, Rüssmann H, Mauch H, Barker M.

Pneumologie. 2012 Apr;66(4):207-11. doi: 10.1055/s-0032-1308914. Epub 2012 Apr 4. German.

20.

Successful oral desensitization to i.v. para-aminosalicylic acid (PAS) using encapsulated PAS dry substance.

Vesenbeckh SM, Becker J, Huhnt C, Karras B, Bauer TT, Mauch H, Rüssmann H, Schönfeld N.

Infection. 2012 Apr;40(2):199-202. doi: 10.1007/s15010-011-0172-y. Epub 2011 Aug 11.

PMID:
21833615
21.

Remote fitting in Nucleus cochlear implant recipients.

Wesarg T, Wasowski A, Skarzynski H, Ramos A, Falcon Gonzalez JC, Kyriafinis G, Junge F, Novakovich A, Mauch H, Laszig R.

Acta Otolaryngol. 2010 Dec;130(12):1379-88. doi: 10.3109/00016489.2010.492480. Epub 2010 Jun 30.

PMID:
20586675
22.

Interferon-gamma release assays improve the diagnosis of tuberculosis and nontuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis.

Detjen AK, Keil T, Roll S, Hauer B, Mauch H, Wahn U, Magdorf K.

Clin Infect Dis. 2007 Aug 1;45(3):322-8. Epub 2007 Jun 15.

PMID:
17599309
23.

A prediction model for bacterial etiology in acute exacerbations of COPD.

Lode H, Allewelt M, Balk S, De Roux A, Mauch H, Niederman M, Schmidt-Ioanas M.

Infection. 2007 Jun;35(3):143-9.

PMID:
17565454
24.

[Pneumocystis jiroveci pneumonia in immunocompromised patients without AIDS -- a case series].

Blum T, Roth A, Mauch H, Erbes R, Lode H.

Dtsch Med Wochenschr. 2006 Jul 7;131(27):1515-20. German.

PMID:
16817100
25.

Characteristics and outcome of patients with active pulmonary tuberculosis requiring intensive care.

Erbes R, Oettel K, Raffenberg M, Mauch H, Schmidt-Ioanas M, Lode H.

Eur Respir J. 2006 Jun;27(6):1223-8. Epub 2006 Feb 15.

26.

[Interferon-gamma assays -- description and assessment of a new tool in the diagnosis of tuberculosis].

Hauer B, Loddenkemper R, Detjen A, Forssbohm M, Haas W, Loytved G, Magdorf K, Mauch H, Nienhaus A, Rieder HL, Sagebiel D, Schaberg T.

Pneumologie. 2006 Jan;60(1):29-44. Review. German.

PMID:
16429390
27.

[The Tuberculosis Rapid Assay from DiaVita - No Alternative to the Tuberculin Skin Test].

Hauer B, Mauch H, Loddenkemper R, Forssbohm M, Früh J, Loytved G, Magdorf K, Priwitzer M, Rüsch-Gerdes S, Schaberg T.

Pneumologie. 2005 Oct;59(10):681-4. German.

PMID:
16222579
28.

Monotherapy of nosocomial pneumonia.

Lode H, Raffenberg M, Geerdes-Fenge H, Mauch H.

Semin Respir Crit Care Med. 2000;21(1):9-17.

PMID:
16088714
29.

Influence of ionizing radiation on nucleus 24 cochlear implants.

Klenzner T, Knapp F, Röhner F, von Wallenberg E, Mauch H, Pedersen P, Aschendorff A, Laszig R, Lutterbach J.

Otol Neurotol. 2005 Jul;26(4):661-7.

PMID:
16015164
30.

Early bactericidal activity of moxifloxacin in treatment of pulmonary tuberculosis: a prospective, randomized study.

Pletz MW, De Roux A, Roth A, Neumann KH, Mauch H, Lode H.

Antimicrob Agents Chemother. 2004 Mar;48(3):780-2.

31.

Ampicillin + sulbactam vs clindamycin +/- cephalosporin for the treatment of aspiration pneumonia and primary lung abscess.

Allewelt M, Schüler P, Bölcskei PL, Mauch H, Lode H; Study Group on Aspiration Pneumonia.

Clin Microbiol Infect. 2004 Feb;10(2):163-70.

32.

Clinical results in the treatment of respiratory infections with moxifloxacin.

Lode H, Lubasch A, Raffenberg M, Mauch H.

Drugs Today (Barc). 2000 Apr;36(4):245-53.

PMID:
12879120
33.

Procalcitonin as a diagnostic tool in lower respiratory tract infections and tuberculosis.

Polzin A, Pletz M, Erbes R, Raffenberg M, Mauch H, Wagner S, Arndt G, Lode H.

Eur Respir J. 2003 Jun;21(6):939-43.

34.

Optimizing ceftazidime pharmacodynamics in patients with acute exacerbation of severe chronic bronchitis.

Lubasch A, Lück S, Lode H, Mauch H, Lorenz J, Bölcskei P, Welte T; COPD Study Group.

J Antimicrob Chemother. 2003 Mar;51(3):659-64.

PMID:
12615868
36.

Nosocomial pneumonia: epidemiology, pathogenesis, diagnosis, treatment and prevention.

Lode H, Raffenberg M, Erbes R, Geerdes-Fenge H, Mauch H.

Curr Opin Infect Dis. 2000 Aug;13(4):377-384.

PMID:
11964806
37.

[Antimycotic treatment of pulmonary aspergilloma in patients without neutropenia].

Grysczyk H, De Roux A, Grassot A, Mauch H, Lode H.

Dtsch Med Wochenschr. 2002 Mar 8;127(10):492-6. German.

PMID:
11884987
38.
39.

[Testing Mycobacterium tuberculosis for drug sensitivity using different methods].

Skriagina EM, Zalutskaia OM, Roth A, Mauch H, Nikolenko EN.

Probl Tuberk. 2001;(5):43-5. Russian.

PMID:
11588962
40.

[Detection of Mycobacterium tuberculosis by different methods].

Skriagina EM, Zalutskaia OM, Roth A, Mauch H, Nikolenko EN.

Probl Tuberk. 2001;(3):56-8. Russian.

PMID:
11508238
41.

Role of long-acting cephalosporins in the treatment of lower respiratory tract infections.

Lode H, Eller J, Raffenberg M, Mauch H.

Clin Microbiol Infect. 2000;6 Suppl 3:87-9. Review. No abstract available.

42.

Sparfloxacin in the treatment of drug resistant tuberculosis or intolerance of first line therapy.

Lubasch A, Erbes R, Mauch H, Lode H.

Eur Respir J. 2001 Apr;17(4):641-6.

43.

[Nosocomial pneumonia. Epidemiology, pathogenesis and diagnosis].

Lode H, Erbes R, Geerdes-Fenge H, Raffenberg M, Mauch H.

Anaesthesist. 2001 Jan;50(1):46-51. Review. German. No abstract available.

PMID:
11220259
44.

[Nosocomial pneumonia. Epidemiology, pathogenesis and diagnosis].

Lode H, Erbes R, Geerdes-Fenge H, Raffenberg M, Mauch H.

Internist (Berl). 2000 Nov;41(11):1170, 1173-6, 1178-9. Review. German. No abstract available.

PMID:
11127220
45.

Mycobacterium heckeshornense sp. nov., A new pathogenic slowly growing Mycobacterium sp. Causing cavitary lung disease in an immunocompetent patient.

Roth A, Reischl U, Schönfeld N, Naumann L, Emler S, Fischer M, Mauch H, Loddenkemper R, Kroppenstedt RM.

J Clin Microbiol. 2000 Nov;38(11):4102-7.

46.

Novel diagnostic algorithm for identification of mycobacteria using genus-specific amplification of the 16S-23S rRNA gene spacer and restriction endonucleases.

Roth A, Reischl U, Streubel A, Naumann L, Kroppenstedt RM, Habicht M, Fischer M, Mauch H.

J Clin Microbiol. 2000 Mar;38(3):1094-104.

47.

[German Society of Pneumology. Recommendations for the diagnosis of nosocomial infections].

Ewig S, Dalhoff K, Lorenz J, Mauch H, Schaberg T, Ukena D, Welte T, Wilkens H, Witt C.

Pneumologie. 1999 Oct;53(10):499-510. Review. German. No abstract available.

PMID:
10596553
48.

Evaluation of IS1245-based PCR for detection of mycobacterium avium bacteraemia in AIDS patients.

Roth A, Fischbach F, Arastéh KN, Futh U, Mauch H.

Scand J Infect Dis. 1999;31(4):393-8.

PMID:
10528880
49.

Infective exacerbations of chronic bronchitis: relation between bacteriologic etiology and lung function.

Eller J, Ede A, Schaberg T, Niederman MS, Mauch H, Lode H.

Chest. 1998 Jun;113(6):1542-8.

PMID:
9631791
50.

[Prevention and therapy of bronchial infections. Recommendations of the German Respiratory League of the German Society of Pneumology].

Worth H, Adam D, Handrick W, Leupold W, Lode H, Loos U, Marre R, Mauch H, Schaberg T, Shah P, Sill V, Wettengel R.

Pneumologie. 1998 Apr;52(4):232-7. German. No abstract available.

PMID:
9610188

Supplemental Content

Support Center